Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase

Bioorg Med Chem Lett. 2016 Oct 1;26(19):4795-4798. doi: 10.1016/j.bmcl.2016.08.024. Epub 2016 Aug 10.

Abstract

Protein tyrosine phosphatases (PTPs) play key roles in many physiological processes, including cell proliferation, differentiation, immune responses and neural activities. Inappropriate regulation of the PTP activity could lead to human diseases, such as cancer or diabetes. Functional studies of PTP can be greatly facilitated by chemical probes that covalently label the active site of a PTP through an activity-dependent chemical reaction. Here, we characterize compound E4 as a new class of PTP activity probes. Compound E4 inactivate STEP in a time- and concentration-dependent fashion. Further study showed that compound E4 inhibits a series of PTPs in a time dependent manner, whereas it shows little or no inhibition toward metal dependent protein phosphatases. Collectively, this new identified covalent inhibitor of PTPs has the potential to be developed to an active site Cys directed PTP probes to study the active properties of the PTPs in cell signaling.

Keywords: Covalent inhibitor; Irreversible; PTP; Probe; STEP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Imidazoles / pharmacology*
  • Kinetics
  • Phosphorylation
  • Protein Tyrosine Phosphatases / antagonists & inhibitors*
  • Thiazoles / pharmacology*

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Thiazoles
  • Protein Tyrosine Phosphatases